{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:49:27Z","timestamp":1768567767898,"version":"3.49.0"},"posted":{"date-parts":[[2024,5,9]]},"group-title":"Genetic and Genomic Medicine","reference-count":64,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,5,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Central serous chorioretinopathy (CSC) is a fluid maculopathy whose etiology is not well understood. Abnormal choroidal veins in CSC patients have been shown to have similarities with varicose veins. To identify potential mechanisms, we analyzed genotype data from 1,477 CSC patients and 455,449 controls in FinnGen. We identified an association for a low-frequency (AF=0.5%) missense variant (rs113791087) in the gene encoding vascular endothelial protein tyrosine phosphatase (VE-PTP) (OR=2.85, P=4.5\u00d710\n                  <jats:sup>-9<\/jats:sup>\n                  ). This was confirmed in a meta-analysis of 2,452 CSC patients and 865,767 controls from 4 studies (OR=3.06, P=7.4\u00d710\n                  <jats:sup>-15<\/jats:sup>\n                  ). Rs113791087 was associated with a 56% higher prevalence of retinal abnormalities (35.3% vs 22.6%, P=8.0x10\n                  <jats:sup>-4<\/jats:sup>\n                  ) in 708 UK Biobank participants and, surprisingly, with varicose veins (OR=1.31, P=2.3x10\n                  <jats:sup>-11<\/jats:sup>\n                  ) and glaucoma (OR=0.82, P=6.9x10\n                  <jats:sup>-9<\/jats:sup>\n                  ). Predicted loss-of-function variants in VEPTP, though rare in number, were associated with CSC in All of Us (OR=17.10, P=0.018). These findings highlight the significance of VE-PTP in diverse ocular and systemic vascular diseases.\n                <\/jats:p>","DOI":"10.1101\/2024.05.08.24307013","type":"posted-content","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T20:50:19Z","timestamp":1715287819000},"source":"Crossref","is-referenced-by-count":1,"title":["Rare genetic variation in VE-PTP is associated with central serous chorioretinopathy, venous dysfunction and glaucoma"],"prefix":"10.64898","author":[{"given":"Joel T","family":"R\u00e4m\u00f6","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Chen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1605-9782","authenticated-orcid":false,"given":"Sean J","family":"Jurgens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panisa","family":"Singhanetr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa G","family":"Tieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elon HC","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher W","family":"Halladay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0322-8970","authenticated-orcid":false,"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Brinks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hoan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"FinnGen, Program VA Million Veteran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saiju","family":"Pyarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cari L","family":"Nealon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2834-2024","authenticated-orcid":false,"given":"Wen-Chih","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Sobrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Kaarniranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Yzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarno","family":"Palotie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal S","family":"Peachey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joni A","family":"Turunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camiel JF","family":"Boon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2067-0533","authenticated-orcid":false,"given":"Patrick T","family":"Ellinor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha K","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J","family":"Rossin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024051308201204000_2024.05.08.24307013v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.02.032"},{"key":"2024051308201204000_2024.05.08.24307013v1.2","unstructured":"Feenstra, H. M. A. et al. Central serous chorioretinopathy: An evidence-based treatment guideline. Prog. Retin. Eye Res. 101236 (2024)."},{"key":"2024051308201204000_2024.05.08.24307013v1.3","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: Towards an evidence-based treatment guideline","volume":"73","year":"2019","journal-title":"Prog. Retin. Eye Res"},{"key":"2024051308201204000_2024.05.08.24307013v1.4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3126\/nepjoph.v11i1.25410","article-title":"Prevalence and Profile of Central Serous Chorioretinopathy in an Indian Cohort","volume":"11","year":"2019","journal-title":"Nepal J. Ophthalmol"},{"key":"2024051308201204000_2024.05.08.24307013v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.049403"},{"key":"2024051308201204000_2024.05.08.24307013v1.6","first-page":"CR51","article-title":"Indocyanine green angiography in chronic central serous chorioretinopathy","volume":"18","year":"2012","journal-title":"Med. Sci. Monit"},{"key":"2024051308201204000_2024.05.08.24307013v1.7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1080\/02713683.2016.1276196","article-title":"Risk Factors for Central Serous Chorioretinopathy: Multivariate Approach in a Case-Control Study","volume":"42","year":"2017","journal-title":"Curr. Eye Res"},{"key":"2024051308201204000_2024.05.08.24307013v1.8","doi-asserted-by":"crossref","first-page":"100973","DOI":"10.1016\/j.preteyeres.2021.100973","article-title":"Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders","volume":"86","year":"2022","journal-title":"Prog. Retin. Eye Res"},{"key":"2024051308201204000_2024.05.08.24307013v1.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.008331"},{"key":"2024051308201204000_2024.05.08.24307013v1.10","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaophthalmol.2018.3190","article-title":"Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study","volume":"136","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"2024051308201204000_2024.05.08.24307013v1.11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s42003-019-0712-z","article-title":"Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy","volume":"2","year":"2019","journal-title":"Commun Biol"},{"key":"2024051308201204000_2024.05.08.24307013v1.12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamaophthalmol.2023.0706","article-title":"Overlap of genetic loci for central serous chorioretinopathy with age-related macular degeneration","volume":"141","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"2024051308201204000_2024.05.08.24307013v1.13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ophtha.2014.09.026","article-title":"Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration","volume":"122","year":"2015","journal-title":"Ophthalmology"},{"key":"2024051308201204000_2024.05.08.24307013v1.14","doi-asserted-by":"crossref","first-page":"100955","DOI":"10.1016\/j.preteyeres.2021.100955","article-title":"Serous business: Delineating the broad spectrum of diseases with subretinal fluid in the macula","volume":"84","year":"2021","journal-title":"Prog. Retin. Eye Res"},{"key":"2024051308201204000_2024.05.08.24307013v1.15","doi-asserted-by":"crossref","first-page":"e00576","DOI":"10.1002\/mgg3.576","article-title":"Exome sequencing in families with chronic central serous chorioretinopathy","volume":"7","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"2024051308201204000_2024.05.08.24307013v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/nature15393"},{"key":"2024051308201204000_2024.05.08.24307013v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.04.025"},{"key":"2024051308201204000_2024.05.08.24307013v1.18","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdf497"},{"key":"2024051308201204000_2024.05.08.24307013v1.19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-0141"},{"key":"2024051308201204000_2024.05.08.24307013v1.20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611510104"},{"key":"2024051308201204000_2024.05.08.24307013v1.21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202992"},{"key":"2024051308201204000_2024.05.08.24307013v1.22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/humu.22551","article-title":"Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy","volume":"35","year":"2014","journal-title":"Hum. Mutat"},{"key":"2024051308201204000_2024.05.08.24307013v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2921"},{"key":"2024051308201204000_2024.05.08.24307013v1.24","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1038\/s41467-022-35188-3","article-title":"Whole-exome sequencing study identifies rare variants and genes associated with intraocular pressure and glaucoma","volume":"13","year":"2022","journal-title":"Nat. Commun"},{"key":"2024051308201204000_2024.05.08.24307013v1.25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85830"},{"key":"2024051308201204000_2024.05.08.24307013v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81814-0"},{"key":"2024051308201204000_2024.05.08.24307013v1.27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI76004"},{"key":"2024051308201204000_2024.05.08.24307013v1.28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI95545"},{"key":"2024051308201204000_2024.05.08.24307013v1.29","doi-asserted-by":"crossref","unstructured":"Chu, M. et al. Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII. Elife 5, (2016).","DOI":"10.7554\/eLife.21032"},{"key":"2024051308201204000_2024.05.08.24307013v1.30","doi-asserted-by":"publisher","DOI":"10.1242\/dev.126.10.2093"},{"key":"2024051308201204000_2024.05.08.24307013v1.31","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.158014"},{"key":"2024051308201204000_2024.05.08.24307013v1.32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI74527"},{"key":"2024051308201204000_2024.05.08.24307013v1.33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20150718"},{"key":"2024051308201204000_2024.05.08.24307013v1.34","doi-asserted-by":"crossref","first-page":"e47046","DOI":"10.15252\/embr.201847046","article-title":"VE-PTP inhibition stabilizes endothelial junctions by activating FGD5","volume":"20","year":"2019","journal-title":"EMBO Rep"},{"key":"2024051308201204000_2024.05.08.24307013v1.35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41433-021-01808-3","article-title":"Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment","volume":"36","year":"2022","journal-title":"Eye"},{"key":"2024051308201204000_2024.05.08.24307013v1.36","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.87.7.603"},{"key":"2024051308201204000_2024.05.08.24307013v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2007.10.019"},{"key":"2024051308201204000_2024.05.08.24307013v1.38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1152\/physiol.00026.2020","article-title":"Vascular Endothelial Protein Tyrosine Phosphatase Regulates Endothelial Function","volume":"36","year":"2021","journal-title":"Physiology"},{"key":"2024051308201204000_2024.05.08.24307013v1.39","doi-asserted-by":"crossref","unstructured":"Karska-Basta, I. et al. Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy. J. Clin. Med. Res. 10, (2021).","DOI":"10.3390\/jcm10051087"},{"key":"2024051308201204000_2024.05.08.24307013v1.40","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5322.55"},{"key":"2024051308201204000_2024.05.08.24307013v1.41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"2024051308201204000_2024.05.08.24307013v1.42","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"2024051308201204000_2024.05.08.24307013v1.43","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.2147\/DDDT.S427416","article-title":"Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies","volume":"17","year":"2023","journal-title":"Drug Des. Devel. Ther"},{"key":"2024051308201204000_2024.05.08.24307013v1.44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94668"},{"key":"2024051308201204000_2024.05.08.24307013v1.45","doi-asserted-by":"crossref","unstructured":"Li, G. et al. A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm\u2019s Canal Increasing Outflow Facility and Reducing Intraocular Pressure. Invest. Ophthalmol. Vis. Sci. 61, 12 (2020).","DOI":"10.1167\/iovs.61.14.12"},{"key":"2024051308201204000_2024.05.08.24307013v1.46","doi-asserted-by":"crossref","unstructured":"Brigell, M. , Withers, B. , Buch, A. & Peters, K. G . Tie2 Activation via VE-PTP Inhibition With Razuprotafib as an Adjunct to Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension. Transl. Vis. Sci. Technol. 11, 7 (2022).","DOI":"10.1167\/tvst.11.1.7"},{"key":"2024051308201204000_2024.05.08.24307013v1.47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008682"},{"key":"2024051308201204000_2024.05.08.24307013v1.48","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41588-023-01428-5","article-title":"Large-scale multitrait genome-wide association analyses identify hundreds of glaucoma risk loci","volume":"55","year":"2023","journal-title":"Nat. Genet"},{"key":"2024051308201204000_2024.05.08.24307013v1.49","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt164"},{"key":"2024051308201204000_2024.05.08.24307013v1.50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/CJI.0000000000000290","article-title":"The VE-PTP Inhibitor AKB-9778 Improves Antitumor Activity and Diminishes the Toxicity of Interleukin 2 (IL-2) Administration","volume":"42","year":"2019","journal-title":"J. Immunother"},{"key":"2024051308201204000_2024.05.08.24307013v1.51","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00618-w"},{"key":"2024051308201204000_2024.05.08.24307013v1.52","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003442"},{"key":"2024051308201204000_2024.05.08.24307013v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.09.016"},{"key":"2024051308201204000_2024.05.08.24307013v1.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.03.004"},{"key":"2024051308201204000_2024.05.08.24307013v1.55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr1809937"},{"key":"2024051308201204000_2024.05.08.24307013v1.56","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0579-z"},{"key":"2024051308201204000_2024.05.08.24307013v1.57","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0164095"},{"key":"2024051308201204000_2024.05.08.24307013v1.58","doi-asserted-by":"publisher","DOI":"10.1038\/S41588-021-00870-7"},{"key":"2024051308201204000_2024.05.08.24307013v1.59","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0184-y"},{"key":"2024051308201204000_2024.05.08.24307013v1.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2019.08.012"},{"key":"2024051308201204000_2024.05.08.24307013v1.61","doi-asserted-by":"publisher","DOI":"10.1093\/BIOINFORMATICS\/BTAB186"},{"key":"2024051308201204000_2024.05.08.24307013v1.62","doi-asserted-by":"publisher","DOI":"10.1101\/2023.06.28.23291975"},{"key":"2024051308201204000_2024.05.08.24307013v1.63","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq126"},{"key":"2024051308201204000_2024.05.08.24307013v1.64","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2308-7"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.05.08.24307013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:00:16Z","timestamp":1768507216000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.05.08.24307013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":64,"URL":"https:\/\/doi.org\/10.1101\/2024.05.08.24307013","relation":{},"subject":[],"published":{"date-parts":[[2024,5,9]]},"subtype":"preprint"}}